Primidone (Mysoline) in the Treatment of Epilepsy
- 16 February 1956
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 254 (7) , 327-329
- https://doi.org/10.1056/nejm195602162540706
Abstract
THE first report dealing with the use of primidone (Mysoline) in the treatment of epilepsy was presented in 1952 by Handley and Stewart.1 Many other investigators2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 subsequently used this drug for the control of epileptic seizures. In 1953 Doyle and Livingston8 analyzed the results obtained in 100 patients with epilepsy who had been given primidone for periods of three months to one year. The purpose of the present paper is to report our findings in a larger group of patients who received this drug for a much longer period.Material for StudyThe drug was administered to 486 patients who . . .Keywords
This publication has 16 references indexed in Scilit:
- Primidone in Mental Deficiency PracticeBMJ, 1954
- Published by BMJ ,1954
- PRIMIDONE IN THE TREATMENT OF NON-IDIOPATHIC EPILEPSYThe Lancet, 1954
- PRIMIDONE (MYSOLINE) IN THE TREATMENT OF CLINICAL PETIT MAL IN CHILDRENThe Lancet, 1954
- TOXIC EFFECTS OF PRIMIDONEThe Lancet, 1954
- The use of mysoline in the treatment of epilepsyThe Journal of Pediatrics, 1953
- MYSOLINE IN THE TREATMENT OF EPILEPSYThe Lancet, 1953
- Value of Primidone in EpilepsyBMJ, 1953
- MYSOLINE IN THE TREATMENT OF EPILEPSYThe Lancet, 1953
- MYSOLINE: A NEW DRUG IN THE TREATMENT OF EPILEPSYThe Lancet, 1952